We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Rinsing Effective at Reducing Infections After Joint Replacement Surgery

By HospiMedica International staff writers
Posted on 28 Feb 2011
A new study finds that a three minute diluted betadine lavage, combined with painting of the skin with a 10% betadine solution prior to surgical closure, nearly eliminates early deep-postoperative infection. More...


Researchers at Rush University Medical Center (RUMC; Chicago, IL, USA) implemented a protocol for primary total knee and total hip arthroplasty in which the wound is soaked with the diluted betadine solution for three minutes following implantation of the prosthetic components. This is followed by a pulsating lavage of normal saline without antibiotics. Prior to final closure, betadine is applied to the skin surrounding the incision.

Acute periprosthetic joint infection--a rare but devastating complication associated with total joint replacement--was diagnosed in 18 out of the 1,862 cases performed prior to the initiation of the betadine protocol, when only saline was used for final lavage. In comparison, only one of the 688 total joint arthroplasties following initiation of this protocol was infected, representing a reduction of the infection rate from 0.97% to 0.15%. No side complications were associated with the treatment. The study was presented at the American Association of Orthopedic Surgeons annual meeting, held during February 2011 in San Diego (CA, USA).

"Betadine is safe, inexpensive, simple to use, and readily available within most operating rooms,” said lead author and study presenter Craig Della Valle, MD, an associate professor of orthopedic surgery at RUMC. "In addition, betadine is effective on many types of bacteria, including methicillin-resistant Staphylococcus Aureus.”

Betadine is a povidone-iodine (PVPI) topical antiseptic available in two formulations - a 10% povidone-iodine solution in water and a "surgical scrub,” which is a mixture of povidone-iodine and detergent, sold over-the-counter (OTC) as a skin cleaner and disinfectant hand wash, and used for cleansing hands prior to surgery and other aseptic procedures. Betadine is also used in hospital settings as part of a regimen for postexposure prophylaxis (PEP).

Related Links:

Rush University Medical Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.